{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:15:09Z","timestamp":1780377309200,"version":"3.54.1"},"publisher-location":"Cham","reference-count":126,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319501727","type":"print"},{"value":"9783319501741","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-50174-1_8","type":"book-chapter","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T13:44:03Z","timestamp":1489758243000},"page":"85-107","source":"Crossref","is-referenced-by-count":52,"title":["Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain"],"prefix":"10.1007","author":[{"given":"Manuel","family":"Merlos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Burgue\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Portillo-Salido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Ram\u00f3n","family":"Plata-Salam\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,18]]},"reference":[{"key":"8_CR1","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.pain.2014.06.020","volume":"155","author":"DG Jamieson","year":"2014","unstructured":"Jamieson DG, Moss A, Kennedy M, Jones S, Nenadic G et al (2014) The pain interactome: connecting pain-specific protein interactions. Pain 155:2243\u20132252","journal-title":"Pain"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","volume":"156","author":"RD Treede","year":"2015","unstructured":"Treede RD, Rief W, Barke A, Aziz Q, Bennett MI et al (2015) A classification of chronic pain for ICD-11. Pain 156:1003\u20131007","journal-title":"Pain"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(11)60402-9","volume":"377","author":"DC Turk","year":"2011","unstructured":"Turk DC, Wilson HD, Cahana A (2011) Treatment of chronic non-cancer pain. Lancet 377:2226\u20132235","journal-title":"Lancet"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1213\/ANE.0b013e3181cde882","volume":"110","author":"I Kissin","year":"2010","unstructured":"Kissin I (2010) The development of new analgesics over the past 50 years: a lack of real breakthrough drugs. Anesth Analg 110:780\u2013789","journal-title":"Anesth Analg"},{"issue":"Suppl 1","key":"8_CR5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/11630080-000000000-00000","volume":"32","author":"R Labianca","year":"2012","unstructured":"Labianca R, Sarzi-Puttini P, Zuccaro SM, Cherubino P, Vellucci R et al (2012) Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. Clin Drug Investig 32(Suppl 1):53\u201363","journal-title":"Clin Drug Investig"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4155\/fmc.14.54","volume":"6","author":"C Almansa","year":"2014","unstructured":"Almansa C, Vela JM (2014) Selective sigma-1 receptor antagonists for the treatment of pain. Future Med Chem 6:1179\u20131199","journal-title":"Future Med Chem"},{"key":"8_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(00)00014-2","volume":"97","author":"G Alonso","year":"2000","unstructured":"Alonso G, Phan V, Guillemain I, Saunier M, Legrand A et al (2000) Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 97:155\u2013170","journal-title":"Neuroscience"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jnr.20390","volume":"79","author":"VL Phan","year":"2005","unstructured":"Phan VL, Miyamoto Y, Nabeshima T, Maurice T (2005) Age-related expression of sigma1 receptors and antidepressant efficacy of a selective agonist in the senescence-accelerated (SAM) mouse. J Neurosci Res 79:561\u2013572","journal-title":"J Neurosci Res"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00213-004-1920-9","volume":"174","author":"X Guitart","year":"2004","unstructured":"Guitart X, Codony X, Monroy X (2004) Sigma receptors: biology and therapeutic potential. Psychopharmacology 174:301\u2013319","journal-title":"Psychopharmacology"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1744-8069-9-47","volume":"9","author":"ML Bangaru","year":"2013","unstructured":"Bangaru ML, Weihrauch D, Tang QB, Zoga V, Hogan Q et al (2013) Sigma-1 receptor expression in sensory neurons and the effect of painful peripheral nerve injury. Mol Pain 9:47","journal-title":"Mol Pain"},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.113.208272","volume":"348","author":"C Sanchez-Fernandez","year":"2014","unstructured":"Sanchez-Fernandez C, Montilla-Garcia A, Gonzalez-Cano R, Nieto FR, Romero L et al (2014) Modulation of peripheral mu-opioid analgesia by sigma1 receptors. J Pharmacol Exp Ther 348:32\u201345","journal-title":"J Pharmacol Exp Ther"},{"key":"8_CR12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2005.01.036","volume":"511","author":"CM Cendan","year":"2005","unstructured":"Cendan CM, Pujalte JM, Portillo-Salido E, Montoliu L, Baeyens JM (2005) Formalin-induced pain is reduced in sigma(1) receptor knockout mice. Eur J Pharmacol 511:73\u201374","journal-title":"Eur J Pharmacol"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pain.2009.03.011","volume":"143","author":"JM Entrena","year":"2009","unstructured":"Entrena JM, Cobos EJ, Nieto FR, Cendan CM, Gris G et al (2009) Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice. Pain 143:252\u2013261","journal-title":"Pain"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pain.2009.05.013","volume":"145","author":"B Puente de la","year":"2009","unstructured":"de la Puente B, Nadal X, Portillo-Salido E, Sanchez-Arroyos R, Ovalle S et al (2009) Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury. Pain 145:294\u2013303","journal-title":"Pain"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jpain.2012.08.006","volume":"13","author":"FR Nieto","year":"2012","unstructured":"Nieto FR, Cendan CM, Sanchez-Fernandez C, Cobos EJ, Entrena JM et al (2012) Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice. J Pain 13:1107\u20131121","journal-title":"J Pain"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/ALN.0b013e318280a60a","volume":"118","author":"R Gonzalez-Cano","year":"2013","unstructured":"Gonzalez-Cano R, Merlos M, Baeyens JM, Cendan CM (2013) Sigma1 receptors are involved in the visceral pain induced by intracolonic administration of capsaicin in mice. Anesthesiology 118:691\u2013700","journal-title":"Anesthesiology"},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-8069-10-11","volume":"10","author":"FR Nieto","year":"2014","unstructured":"Nieto FR, Cendan CM, Canizares FJ, Cubero MA, Vela JM et al (2014) Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice. Mol Pain 10:11","journal-title":"Mol Pain"},{"key":"8_CR18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/FBP.0000000000000038","volume":"25","author":"G Gris","year":"2014","unstructured":"Gris G, Merlos M, Vela JM, Zamanillo D, Portillo-Salido E (2014) S1RA, a selective sigma-1 receptor antagonist, inhibits inflammatory pain in the carrageenan and complete Freund\u2019s adjuvant models in mice. Behav Pharmacol 25:226\u2013235","journal-title":"Behav Pharmacol"},{"key":"8_CR19","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1007\/s00213-014-3524-3","volume":"231","author":"MA Tejada","year":"2014","unstructured":"Tejada MA, Montilla-Garcia A, Sanchez-Fernandez C, Entrena JM, Perazzoli G et al (2014) Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors. Psychopharmacology 231:3855\u20133869","journal-title":"Psychopharmacology"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/13543784.2015.1048334","volume":"24","author":"JM Vela","year":"2015","unstructured":"Vela JM, Merlos M, Almansa C (2015) Investigational sigma-1 receptor antagonists for the treatment of pain. Expert Opin Investig Drugs 24:883\u2013896","journal-title":"Expert Opin Investig Drugs"},{"key":"8_CR21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0022-3565(25)24045-9","volume":"271","author":"CC Chien","year":"1994","unstructured":"Chien CC, Pasternak GW (1994) Selective antagonism of opioid analgesia by a sigma system. J Pharmacol Exp Ther 271:1583\u20131590","journal-title":"J Pharmacol Exp Ther"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2013.04.018","volume":"711","author":"A Vidal-Torres","year":"2013","unstructured":"Vidal-Torres A, de la Puente B, Rocasalbas M, Tourino C, Bura SA et al (2013) Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects. Eur J Pharmacol 711:63\u201372","journal-title":"Eur J Pharmacol"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neuropharm.2013.03.002","volume":"70","author":"C Sanchez-Fernandez","year":"2013","unstructured":"Sanchez-Fernandez C, Nieto FR, Gonzalez-Cano R, Artacho-Cordon A, Romero L et al (2013) Potentiation of morphine-induced mechanical antinociception by sigma(1) receptor inhibition: role of peripheral sigma(1) receptors. Neuropharmacology 70:348\u2013358","journal-title":"Neuropharmacology"},{"key":"8_CR24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(95)11504-P","volume":"190","author":"CC Chien","year":"1995","unstructured":"Chien CC, Pasternak GW (1995) Sigma antagonists potentiate opioid analgesia in rats. Neurosci Lett 190:137\u2013139","journal-title":"Neurosci Lett"},{"key":"8_CR25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/bjp.2008.159","volume":"154","author":"HW Kim","year":"2008","unstructured":"Kim HW, Roh DH, Yoon SY, Seo HS, Kwon YB et al (2008) Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice. Br J Pharmacol 154:1125\u20131134","journal-title":"Br J Pharmacol"},{"key":"8_CR26","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/j.1476-5381.2012.01942.x","volume":"166","author":"L Romero","year":"2012","unstructured":"Romero L, Zamanillo D, Nadal X, Sanchez-Arroyos R, Rivera-Arconada I et al (2012) Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization. Br J Pharmacol 166:2289\u20132306","journal-title":"Br J Pharmacol"},{"key":"8_CR27","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/0014-2999(93)90650-7","volume":"250","author":"CC Chien","year":"1993","unstructured":"Chien CC, Pasternak GW (1993) Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid sigma 1 system. Eur J Pharmacol 250:R7\u2013R8","journal-title":"Eur J Pharmacol"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/jpet.300.3.1070","volume":"300","author":"J Mei","year":"2002","unstructured":"Mei J, Pasternak GW (2002) Sigma1 receptor modulation of opioid analgesia in the mouse. J Pharmacol Exp Ther 300:1070\u20131074","journal-title":"J Pharmacol Exp Ther"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(98)00048-3","volume":"57","author":"MJ Millan","year":"1999","unstructured":"Millan MJ (1999) The induction of pain: an integrative review. Prog Neurobiol 57:1\u2013164","journal-title":"Prog Neurobiol"},{"issue":"Suppl 3","key":"8_CR30","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1111\/j.1526-4637.2011.01158.x","volume":"12","author":"M Liu","year":"2011","unstructured":"Liu M, Wood JN (2011) The roles of sodium channels in nociception: implications for mechanisms of neuropathic pain. Pain Med 12(Suppl 3):S93\u2013S99","journal-title":"Pain Med"},{"key":"8_CR31","doi-asserted-by":"crossref","first-page":"37021","DOI":"10.1074\/jbc.M112.382077","volume":"287","author":"D Balasuriya","year":"2012","unstructured":"Balasuriya D, Stewart AP, Crottes D, Borgese F, Soriani O et al (2012) The sigma-1 receptor binds to the Nav1.5 voltage-gated Na+ channel with 4-fold symmetry. J Biol Chem 287:37021\u201337029","journal-title":"J Biol Chem"},{"key":"8_CR32","doi-asserted-by":"crossref","first-page":"C1049","DOI":"10.1152\/ajpcell.00431.2008","volume":"296","author":"M Johannessen","year":"2009","unstructured":"Johannessen M, Ramachandran S, Riemer L, Ramos-Serrano A, Ruoho AE et al (2009) Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems. Am J Physiol Cell Physiol 296:C1049\u2013C1057","journal-title":"Am J Physiol Cell Physiol"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"C328","DOI":"10.1152\/ajpcell.00383.2010","volume":"300","author":"M Johannessen","year":"2011","unstructured":"Johannessen M, Fontanilla D, Mavlyutov T, Ruoho AE, Jackson MB (2011) Antagonist action of progesterone at sigma-receptors in the modulation of voltage-gated sodium channels. Am J Physiol Cell Physiol 300:C328\u2013C337","journal-title":"Am J Physiol Cell Physiol"},{"key":"8_CR34","first-page":"1","volume":"2","author":"H Zhang","year":"2009","unstructured":"Zhang H, Katnik C, Cuevas J (2009) Sigma receptor activation inhibits voltage-gated sodium channels in rat intracardiac ganglion neurons. Int J Physiol Pathophysiol Pharmacol 2:1\u201311","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"8_CR35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.expneurol.2007.10.004","volume":"210","author":"ZX Cheng","year":"2008","unstructured":"Cheng ZX, Lan DM, Wu PY, Zhu YH, Dong Y et al (2008) Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors. Exp Neurol 210:128\u2013136","journal-title":"Exp Neurol"},{"issue":"Suppl","key":"8_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/ABiol.59.2008.Suppl.1","volume":"59","author":"T Kiss","year":"2008","unstructured":"Kiss T (2008) Persistent Na-channels: origin and function. A Rev Acta Biol Hung 59(Suppl):1\u201312","journal-title":"A Rev Acta Biol Hung"},{"key":"8_CR37","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1152\/jn.00113.2015","volume":"113","author":"C Han","year":"2015","unstructured":"Han C, Estacion M, Huang J, Vasylyev D, Zhao P et al (2015) Human Na(v)1.8: enhanced persistent and ramp currents contribute to distinct firing properties of human DRG neurons. J Neurophysiol 113:3172\u20133185","journal-title":"J Neurophysiol"},{"key":"8_CR38","volume":"7","author":"XF Gao","year":"2012","unstructured":"Gao XF, Yao JJ, He YL, Hu C, Mei YA (2012) Sigma-1 receptor agonists directly inhibit Nav1.2\/1.4 channels. PLoS One 7:e49384","journal-title":"PLoS One"},{"key":"8_CR39","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1134\/S0006297914130069","volume":"79","author":"DI Osmakov","year":"2014","unstructured":"Osmakov DI, Andreev YA, Kozlov SA (2014) Acid-sensing ion channels and their modulators. Biochemistry (Mosc) 79:1528\u20131545","journal-title":"Biochemistry (Mosc)"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bpj.2009.12.4293","volume":"98","author":"SM Carnally","year":"2010","unstructured":"Carnally SM, Johannessen M, Henderson RM, Jackson MB, Edwardson JM (2010) Demonstration of a direct interaction between sigma-1 receptors and acid-sensing ion channels. Biophys J 98:1182\u20131191","journal-title":"Biophys J"},{"key":"8_CR41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1124\/jpet.108.143974","volume":"327","author":"Y Herrera","year":"2008","unstructured":"Herrera Y, Katnik C, Rodriguez JD, Hall AA, Willing A et al (2008) Sigma-1 receptor modulation of acid-sensing ion channel a (ASIC1a) and ASIC1a-induced Ca2+ influx in rat cortical neurons. J Pharmacol Exp Ther 327:491\u2013502","journal-title":"J Pharmacol Exp Ther"},{"key":"8_CR42","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ejp.774","volume":"20","author":"SG Kwon","year":"2016","unstructured":"Kwon SG, Roh DH, Yoon SY, Choi SR, Choi HS et al (2016) Role of peripheral sigma-1 receptors in ischaemic pain: potential interactions with ASIC and P2X receptors. Eur J Pain 20:594\u2013606","journal-title":"Eur J Pain"},{"key":"8_CR43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tins.2013.12.002","volume":"37","author":"C Tsantoulas","year":"2014","unstructured":"Tsantoulas C, McMahon SB (2014) Opening paths to novel analgesics: the role of potassium channels in chronic pain. Trends Neurosci 37:146\u2013158","journal-title":"Trends Neurosci"},{"key":"8_CR44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2012.12.004","volume":"152","author":"S Kourrich","year":"2013","unstructured":"Kourrich S, Hayashi T, Chuang JY, Tsai SY, Su TP et al (2013) Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 152:236\u2013247","journal-title":"Cell"},{"key":"8_CR45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0896-6273(02)00677-3","volume":"34","author":"E Aydar","year":"2002","unstructured":"Aydar E, Palmer CP, Klyachko VA, Jackson MB (2002) The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34:399\u2013410","journal-title":"Neuron"},{"key":"8_CR46","doi-asserted-by":"crossref","first-page":"13373","DOI":"10.1073\/pnas.231376298","volume":"98","author":"MN Rasband","year":"2001","unstructured":"Rasband MN, Park EW, Vanderah TW, Lai J, Porreca F et al (2001) Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci U S A 98:13373\u201313378","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1113\/jphysiol.2006.116178","volume":"578","author":"M Martina","year":"2007","unstructured":"Martina M, Turcotte ME, Halman S, Bergeron R (2007) The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 578:143\u2013157","journal-title":"J Physiol"},{"key":"8_CR48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0959-4388(98)80056-1","volume":"8","author":"C Vergara","year":"1998","unstructured":"Vergara C, Latorre R, Marrion NV, Adelman JP (1998) Calcium-activated potassium channels. Curr Opin Neurobiol 8:321\u2013329","journal-title":"Curr Opin Neurobiol"},{"key":"8_CR49","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nn1449","volume":"8","author":"TJ Ngo-Anh","year":"2005","unstructured":"Ngo-Anh TJ, Bloodgood BL, Lin M, Sabatini BL, Maylie J et al (2005) SK channels and NMDA receptors form a Ca2+\u2212mediated feedback loop in dendritic spines. Nat Neurosci 8:642\u2013649","journal-title":"Nat Neurosci"},{"key":"8_CR50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2010.05.008","volume":"641","author":"C Lamy","year":"2010","unstructured":"Lamy C, Scuvee-Moreau J, Dilly S, Liegeois JF, Seutin V (2010) The sigma agonist 1,3-di-o-tolyl-guanidine directly blocks SK channels in dopaminergic neurons and in cell lines. Eur J Pharmacol 641:23\u201328","journal-title":"Eur J Pharmacol"},{"key":"8_CR51","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.nurt.2009.07.006","volume":"6","author":"D Perret","year":"2009","unstructured":"Perret D, Luo ZD (2009) Targeting voltage-gated calcium channels for neuropathic pain management. Neurotherapeutics 6:679\u2013692","journal-title":"Neurotherapeutics"},{"key":"8_CR52","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1167\/iovs.08-1867","volume":"49","author":"KT Tchedre","year":"2008","unstructured":"Tchedre KT, Huang RQ, Dibas A, Krishnamoorthy RR, Dillon GH et al (2008) Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. Invest Ophthalmol Vis Sci 49:4993\u20135002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exer.2012.11.002","volume":"107","author":"BH Mueller 2nd","year":"2013","unstructured":"Mueller BH 2nd, Park Y, Daudt DR 3rd, Ma HY, Akopova I et al (2013) Sigma-1 receptor stimulation attenuates calcium influx through activated L-type voltage gated calcium channels in purified retinal ganglion cells. Exp Eye Res 107:21\u201331","journal-title":"Exp Eye Res"},{"key":"8_CR54","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1152\/jn.2002.87.6.2867","volume":"87","author":"H Zhang","year":"2002","unstructured":"Zhang H, Cuevas J (2002) Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87:2867\u20132879","journal-title":"J Neurophysiol"},{"key":"8_CR55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/jpet.114.214320","volume":"350","author":"B Pan","year":"2014","unstructured":"Pan B, Guo Y, Kwok WM, Hogan Q, Wu HE (2014) Sigma-1 receptor antagonism restores injury-induced decrease of voltage-gated Ca2+ current in sensory neurons. J Pharmacol Exp Ther 350:290\u2013300","journal-title":"J Pharmacol Exp Ther"},{"key":"8_CR56","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1124\/jpet.103.053447","volume":"307","author":"FP Monnet","year":"2003","unstructured":"Monnet FP, Morin-Surun MP, Leger J, Combettes L (2003) Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons. J Pharmacol Exp Ther 307:705\u2013712","journal-title":"J Pharmacol Exp Ther"},{"key":"8_CR57","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/ALN.0b013e3181895a83","volume":"109","author":"DH Roh","year":"2008","unstructured":"Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB et al (2008) Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain. Anesthesiology 109:879\u2013889","journal-title":"Anesthesiology"},{"key":"8_CR58","doi-asserted-by":"crossref","first-page":"18219","DOI":"10.1523\/JNEUROSCI.3360-13.2013","volume":"33","author":"D Balasuriya","year":"2013","unstructured":"Balasuriya D, Stewart AP, Edwardson JM (2013) The sigma-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1\/GluN2A NMDA receptor. J Neurosci 33:18219\u201318224","journal-title":"J Neurosci"},{"key":"8_CR59","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1017\/S1461145714000029","volume":"17","author":"P Sanchez-Blazquez","year":"2014","unstructured":"Sanchez-Blazquez P, Rodriguez-Munoz M, Herrero-Labrador R, Burgueno J, Zamanillo D et al (2014) The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. Int J Neuropsychopharmacol 17:1943\u20131955","journal-title":"Int J Neuropsychopharmacol"},{"key":"8_CR60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/ars.2014.5993","volume":"22","author":"M Rodriguez-Munoz","year":"2015","unstructured":"Rodriguez-Munoz M, Sanchez-Blazquez P, Herrero-Labrador R, Martinez-Murillo R, Merlos M et al (2015) The sigma1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control. Antioxid Redox Signal 22:799\u2013818","journal-title":"Antioxid Redox Signal"},{"key":"8_CR61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0893-133X(95)00084-Q","volume":"13","author":"GW Pasternak","year":"1995","unstructured":"Pasternak GW, Kolesnikov YA, Babey AM (1995) Perspectives on the N-methyl-D-aspartate\/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology 13:309\u2013313","journal-title":"Neuropsychopharmacology"},{"key":"8_CR62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1874473711205030199","volume":"5","author":"J Garzon","year":"2012","unstructured":"Garzon J, Rodriguez-Munoz M, Sanchez-Blazquez P (2012) Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance. Curr Drug Abuse Rev 5:199\u2013226","journal-title":"Curr Drug Abuse Rev"},{"key":"8_CR63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/1467-9450.00281","volume":"43","author":"LJ Rygh","year":"2002","unstructured":"Rygh LJ, Tjolsen A, Hole K, Svendsen F (2002) Cellular memory in spinal nociceptive circuitry. Scand J Psychol 43:153\u2013159","journal-title":"Scand J Psychol"},{"key":"8_CR64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3959(00)00424-3","volume":"88","author":"J Sandkuhler","year":"2000","unstructured":"Sandkuhler J (2000) Learning and memory in pain pathways. Pain 88:113\u2013118","journal-title":"Pain"},{"key":"8_CR65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fphar.2013.00169","volume":"4","author":"P Sanchez-Blazquez","year":"2014","unstructured":"Sanchez-Blazquez P, Rodriguez-Munoz M, Garzon J (2014) The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia. Front Pharmacol 4:169","journal-title":"Front Pharmacol"},{"key":"8_CR66","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/mol.109.057083","volume":"77","author":"FJ Kim","year":"2010","unstructured":"Kim FJ, Kovalyshyn I, Burgman M, Neilan C, Chien CC et al (2010) Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Mol Pharmacol 77:695\u2013703","journal-title":"Mol Pharmacol"},{"key":"8_CR67","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.2013.53.1079","volume":"32","author":"GW Pasternak","year":"2014","unstructured":"Pasternak GW (2014) Opiate pharmacology and relief of pain. J Clin Oncol 32:1655\u20131661","journal-title":"J Clin Oncol"},{"key":"8_CR68","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/phar.1642","volume":"35","author":"EA Romero-Sandoval","year":"2015","unstructured":"Romero-Sandoval EA, Asbill S, Paige CA, Byrd-Glover K (2015) Peripherally restricted cannabinoids for the treatment of pain. Pharmacotherapy 35:917\u2013925","journal-title":"Pharmacotherapy"},{"key":"8_CR69","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuropharm.2014.10.022","volume":"89","author":"J Garzon","year":"2015","unstructured":"Garzon J, Herrero-Labrador R, Rodriguez-Munoz M, Shah R, Vicente-Sanchez A et al (2015) HINT1 protein: a new therapeutic target to enhance opioid antinociception and block mechanical allodynia. Neuropharmacology 89:412\u2013423","journal-title":"Neuropharmacology"},{"key":"8_CR70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pain.2011.10.014","volume":"153","author":"A Tappe-Theodor","year":"2012","unstructured":"Tappe-Theodor A, Constantin CE, Tegeder I, Lechner SG, Langeslag M et al (2012) Galpha(q\/11) signaling tonically modulates nociceptor function and contributes to activity-dependent sensitization. Pain 153:184\u2013196","journal-title":"Pain"},{"issue":"14","key":"8_CR71","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1073\/pnas.96.14.8196","volume":"96","author":"MP Morin-Surun","year":"1999","unstructured":"Morin-Surun MP et al (1999) Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci USA 96(14):8196\u20138199","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR72","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1073\/pnas.98.2.491","volume":"98","author":"T Hayashi","year":"2001","unstructured":"Hayashi T, Su TP (2001) Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc Natl Acad Sci U S A 98:491\u2013496","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR73","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","volume":"131","author":"T Hayashi","year":"2007","unstructured":"Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131:596\u2013610","journal-title":"Cell"},{"key":"8_CR74","doi-asserted-by":"crossref","first-page":"23318","DOI":"10.1074\/jbc.M112.349142","volume":"287","author":"N Shioda","year":"2012","unstructured":"Shioda N, Ishikawa K, Tagashira H, Ishizuka T, Yawo H et al (2012) Expression of a truncated form of the endoplasmic reticulum chaperone protein, sigma1 receptor, promotes mitochondrial energy depletion and apoptosis. J Biol Chem 287:23318\u201323331","journal-title":"J Biol Chem"},{"key":"8_CR75","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)39299-7","volume":"293","author":"T Hayashi","year":"2000","unstructured":"Hayashi T, Maurice T, Su TP (2000) Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J Pharmacol Exp Ther 293:788\u2013798","journal-title":"J Pharmacol Exp Ther"},{"key":"8_CR76","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/mol.107.038307","volume":"72","author":"A Pal","year":"2007","unstructured":"Pal A, Hajipour AR, Fontanilla D, Ramachandran S, Chu UB et al (2007) Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. Mol Pharmacol 72:921\u2013933","journal-title":"Mol Pharmacol"},{"key":"8_CR77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20141321","volume":"466","author":"AK Mishra","year":"2015","unstructured":"Mishra AK, Mavlyutov T, Singh DR, Biener G, Yang J et al (2015) The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. Biochem J 466:263\u2013271","journal-title":"Biochem J"},{"key":"8_CR78","doi-asserted-by":"crossref","first-page":"20333","DOI":"10.1074\/jbc.M113.537993","volume":"289","author":"KA Gromek","year":"2014","unstructured":"Gromek KA, Suchy FP, Meddaugh HR, Wrobel RL, LaPointe LM et al (2014) The oligomeric states of the purified sigma-1 receptor are stabilized by ligands. J Biol Chem 289:20333\u201320344","journal-title":"J Biol Chem"},{"key":"8_CR79","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","volume":"93","author":"M Hanner","year":"1996","unstructured":"Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J et al (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A 93:8072\u20138077","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR80","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1996.1842","volume":"229","author":"R Kekuda","year":"1996","unstructured":"Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V (1996) Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 229:553\u2013558","journal-title":"Biochem Biophys Res Commun"},{"key":"8_CR81","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1021\/jm3007323","volume":"55","author":"JL Diaz","year":"2012","unstructured":"Diaz JL, Cuberes R, Berrocal J, Contijoch M, Christmann U et al (2012) Synthesis and biological evaluation of the 1-arylpyrazole class of sigma(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862). J Med Chem 55:8211\u20138224","journal-title":"J Med Chem"},{"key":"8_CR82","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/j.1532-2149.2012.00251.x","volume":"17","author":"AS Bura","year":"2013","unstructured":"Bura AS, Guegan T, Zamanillo D, Vela JM, Maldonado R (2013) Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain. Eur J Pain 17:832\u2013843","journal-title":"Eur J Pain"},{"key":"8_CR83","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ejp.629","volume":"19","author":"I Mazo","year":"2015","unstructured":"Mazo I, Roza C, Zamanillo D, Merlos M, Vela JM et al (2015) Effects of centrally acting analgesics on spinal segmental reflexes and wind-up. Eur J Pain 19:1012\u20131020","journal-title":"Eur J Pain"},{"key":"8_CR84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2125.2012.04333.x","volume":"75","author":"M Abadias","year":"2013","unstructured":"Abadias M, Escriche M, Vaque A, Sust M, Encina G (2013) Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies. Br J Clin Pharmacol 75:103\u2013117","journal-title":"Br J Clin Pharmacol"},{"key":"8_CR85","doi-asserted-by":"crossref","first-page":"e0136369","DOI":"10.1371\/journal.pone.0136369","volume":"10","author":"J Taubel","year":"2015","unstructured":"Taubel J, Ferber G, Lorch U, Wang D, Sust M et al (2015) Single doses up to 800 mg of E-52862 do not prolong the QTc interval \u2013 a retrospective validation by pharmacokinetic-pharmacodynamic modelling of electrocardiography data utilising the effects of a meal on QTc to demonstrate ECG assay sensitivity. PLoS One 10:e0136369","journal-title":"PLoS One"},{"key":"8_CR86","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","volume":"63","author":"A Kurz","year":"2003","unstructured":"Kurz A, Sessler DI (2003) Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 63:649\u2013671","journal-title":"Drugs"},{"key":"8_CR87","doi-asserted-by":"crossref","first-page":"e004521","DOI":"10.1136\/bmjopen-2013-004521","volume":"4","author":"AS Reece","year":"2014","unstructured":"Reece AS, Hulse GK (2014) Impact of lifetime opioid exposure on arterial stiffness and vascular age: cross-sectional and longitudinal studies in men and women. BMJ Open 4:e004521","journal-title":"BMJ Open"},{"key":"8_CR88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(95)00552-8","volume":"294","author":"CC Chien","year":"1995","unstructured":"Chien CC, Pasternak GW (1995) (\u2212)-Pentazocine analgesia in mice: interactions with a sigma receptor system. Eur J Pharmacol 294:303\u2013308","journal-title":"Eur J Pharmacol"},{"key":"8_CR89","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/S0014-2999(97)01064-9","volume":"331","author":"M King","year":"1997","unstructured":"King M, Pan YX, Mei J, Chang A, Xu J et al (1997) Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor. Eur J Pharmacol 331:R5\u2013R6","journal-title":"Eur J Pharmacol"},{"key":"8_CR90","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0928-0987(00)00157-3","volume":"12","author":"G Ronsisvalle","year":"2001","unstructured":"Ronsisvalle G, Prezzavento O, Marrazzo A, Vittorio F, Bousquet E et al (2001) Synthesis and binding affinity of cis-(\u2212)- and cis-(+)-N-ethyleneamino-N-nordeoxymetazocine and cis-(\u2212)-N-normetazocine analogues at sigma1, sigma2 and kappa opioid receptors. Eur J Pharm Sci 12:277\u2013284","journal-title":"Eur J Pharm Sci"},{"key":"8_CR91","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2007.11.032","volume":"82","author":"O Prezzavento","year":"2008","unstructured":"Prezzavento O, Parenti C, Marrazzo A, Ronsisvalle S, Vittorio F et al (2008) A new sigma ligand, (+\/\u2212)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect. Life Sci 82:549\u2013553","journal-title":"Life Sci"},{"key":"8_CR92","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.lfs.2005.10.005","volume":"78","author":"A Marrazzo","year":"2006","unstructured":"Marrazzo A, Parenti C, Scavo V, Ronsisvalle S, Scoto GM et al (2006) In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia. Life Sci 78:2449\u20132453","journal-title":"Life Sci"},{"key":"8_CR93","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/1871524910909030172","volume":"9","author":"JL Diaz","year":"2009","unstructured":"Diaz JL, Zamanillo D, Corbera J, Baeyens JM, Maldonado R et al (2009) Selective sigma-1 (sigma1) receptor antagonists: emerging target for the treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem 9:172\u2013183","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"8_CR94","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1046\/j.1471-4159.1998.70062279.x","volume":"70","author":"YX Pan","year":"1998","unstructured":"Pan YX, Mei J, Xu J, Wan BL, Zuckerman A et al (1998) Cloning and characterization of a mouse sigma1 receptor. J Neurochem 70:2279\u20132285","journal-title":"J Neurochem"},{"key":"8_CR95","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.107.121137","volume":"322","author":"J Mei","year":"2007","unstructured":"Mei J, Pasternak GW (2007) Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study. J Pharmacol Exp Ther 322:1278\u20131285","journal-title":"J Pharmacol Exp Ther"},{"key":"8_CR96","unstructured":"Vidal-Torres AF-PB, Carceller A, Vela JM, Merlos M, Zamanillo D (2014) Supraspinal and peripheral but not intrathecal sigma-1 receptor blockade by the selective sigma-1 receptor antagonist E-52862 enhances morphine antinociception. 15th World Congress on Pain. Buenos Aires"},{"key":"8_CR97","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1248\/bpb.b15-00183","volume":"38","author":"SY Yoon","year":"2015","unstructured":"Yoon SY, Kang SY, Kim HW, Kim HC, Roh DH (2015) Clonidine reduces nociceptive responses in mouse orofacial formalin model: potentiation by sigma-1 receptor antagonist BD1047 without impaired motor coordination. Biol Pharm Bull 38:1320\u20131327","journal-title":"Biol Pharm Bull"},{"key":"8_CR98","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aen107","volume":"101","author":"A Dray","year":"2008","unstructured":"Dray A (2008) Neuropathic pain: emerging treatments. Br J Anaesth 101:48\u201358","journal-title":"Br J Anaesth"},{"key":"8_CR99","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00213-005-0127-z","volume":"182","author":"CM Cendan","year":"2005","unstructured":"Cendan CM, Pujalte JM, Portillo-Salido E, Baeyens JM (2005) Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. Psychopharmacology 182:485\u2013493","journal-title":"Psychopharmacology"},{"key":"8_CR100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-009-1513-8","volume":"205","author":"JM Entrena","year":"2009","unstructured":"Entrena JM, Cobos EJ, Nieto FR, Cendan CM, Baeyens JM et al (2009) Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors. Psychopharmacology 205:21\u201333","journal-title":"Psychopharmacology"},{"key":"8_CR101","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4196\/kjpp.2010.14.6.359","volume":"14","author":"JS Son","year":"2010","unstructured":"Son JS, Kwon YB (2010) Sigma-1 receptor antagonist BD1047 reduces allodynia and spinal ERK phosphorylation following chronic compression of dorsal root ganglion in rats. Korean J Physiol Pharmacol 14:359\u2013364","journal-title":"Korean J Physiol Pharmacol"},{"key":"8_CR102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2010.05.005","volume":"641","author":"M Ohsawa","year":"2010","unstructured":"Ohsawa M, Hayashi SS, Kamei J (2010) Effect of acute topical application of +\u2212pentazocine on the mechanical allodynia in diabetic mice. Eur J Pharmacol 641:49\u201353","journal-title":"Eur J Pharmacol"},{"key":"8_CR103","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/syn.21844","volume":"69","author":"M Tomohisa","year":"2015","unstructured":"Tomohisa M, Junpei O, Aki M, Masato H, Mika F et al (2015) Possible involvement of the Sigma-1 receptor chaperone in chemotherapeutic-induced neuropathic pain. Synapse 69:526\u2013532","journal-title":"Synapse"},{"key":"8_CR104","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1111\/bph.12893","volume":"171","author":"JY Moon","year":"2014","unstructured":"Moon JY, Roh DH, Yoon SY, Choi SR, Kwon SG et al (2014) sigma1 receptors activate astrocytes via p38 MAPK phosphorylation leading to the development of mechanical allodynia in a mouse model of neuropathic pain. Br J Pharmacol 171:5881\u20135897","journal-title":"Br J Pharmacol"},{"key":"8_CR105","doi-asserted-by":"crossref","first-page":"PL281","DOI":"10.1016\/S0024-3205(99)00521-4","volume":"65","author":"K Mardon","year":"1999","unstructured":"Mardon K, Kassiou M, Donald A (1999) Effects of streptozotocin-induced diabetes on neuronal sigma receptors in the rat brain. Life Sci 65:PL281\u2013PL286","journal-title":"Life Sci"},{"key":"8_CR106","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00011-015-0819-8","volume":"64","author":"G Gris","year":"2015","unstructured":"Gris G, Cobos EJ, Zamanillo D, Portillo-Salido E (2015) Sigma-1 receptor and inflammatory pain. Inflamm Res 64:377\u2013381","journal-title":"Inflamm Res"},{"key":"8_CR107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/157015906778019554","volume":"4","author":"J Huang","year":"2006","unstructured":"Huang J, Zhang X, McNaughton PA (2006) Inflammatory pain: the cellular basis of heat hyperalgesia. Curr Neuropharmacol 4:197\u2013206","journal-title":"Curr Neuropharmacol"},{"key":"8_CR108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00011-013-0692-2","volume":"63","author":"C Parenti","year":"2014","unstructured":"Parenti C, Marrazzo A, Arico G, Parenti R, Pasquinucci L et al (2014) The antagonistic effect of the sigma 1 receptor ligand (+)-MR200 on persistent pain induced by inflammation. Inflamm Res 63:231\u2013237","journal-title":"Inflamm Res"},{"key":"8_CR109","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10753-013-9736-6","volume":"37","author":"C Parenti","year":"2014","unstructured":"Parenti C, Marrazzo A, Arico G, Cantarella G, Prezzavento O et al (2014) Effects of a selective sigma 1 antagonist compound on inflammatory pain. Inflammation 37:261\u2013266","journal-title":"Inflammation"},{"key":"8_CR110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2015.12.012","volume":"771","author":"BA Garcia-Martinez","year":"2016","unstructured":"Garcia-Martinez BA, Jaramillo-Morales OA, Espinosa-Juarez JV, Navarrete-Vazquez G, Melo-Hernandez LA et al (2016) Antinociceptive effects of a new sigma-1 receptor antagonist (N-(2-morpholin-4-yl-ethyl)-2-(1-naphthyloxy)acetamide) in two types of nociception. Eur J Pharmacol 771:10\u201317","journal-title":"Eur J Pharmacol"},{"key":"8_CR111","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainresbull.2015.07.006","volume":"119","author":"YC Jeong","year":"2015","unstructured":"Jeong YC, Son JS, Kwon YB (2015) The spinal antinociceptive mechanism determined by systemic administration of BD1047 in zymosan-induced hyperalgesia in rats. Brain Res Bull 119:93\u2013100","journal-title":"Brain Res Bull"},{"key":"8_CR112","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1476-5381.2011.01316.x","volume":"163","author":"DH Roh","year":"2011","unstructured":"Roh DH, Choi SR, Yoon SY, Kang SY, Moon JY et al (2011) Spinal neuronal NOS activation mediates sigma-1 receptor-induced mechanical and thermal hypersensitivity in mice: involvement of PKC-dependent GluN1 phosphorylation. Br J Pharmacol 163:1707\u20131720","journal-title":"Br J Pharmacol"},{"key":"8_CR113","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bbadis.2010.12.011","volume":"1812","author":"JJ McDougall","year":"2011","unstructured":"McDougall JJ (2011) Peripheral analgesia: Hitting pain where it hurts. Biochim Biophys Acta 1812:459\u2013467","journal-title":"Biochim Biophys Acta"},{"key":"8_CR114","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2014.04.006","volume":"734","author":"J Sawynok","year":"2014","unstructured":"Sawynok J, Liu J (2014) Contributions of peripheral, spinal, and supraspinal actions to analgesia. Eur J Pharmacol 734:114\u2013121","journal-title":"Eur J Pharmacol"},{"key":"8_CR115","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(99)01306-9","volume":"353","author":"F Cervero","year":"1999","unstructured":"Cervero F, Laird JM (1999) Visceral pain. Lancet 353:2145\u20132148","journal-title":"Lancet"},{"key":"8_CR116","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/SPC.0b013e32834f6ec9","volume":"6","author":"S Sikandar","year":"2012","unstructured":"Sikandar S, Dickenson AH (2012) Visceral pain: the ins and outs, the ups and downs. Curr Opin Support Palliat Care 6:17\u201326","journal-title":"Curr Opin Support Palliat Care"},{"key":"8_CR117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/JPR.S37593","volume":"7","author":"M Romero-Reyes","year":"2014","unstructured":"Romero-Reyes M, Uyanik JM (2014) Orofacial pain management: current perspectives. J Pain Res 7:99\u2013115","journal-title":"J Pain Res"},{"key":"8_CR118","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.coms.2007.12.009","volume":"20","author":"JP Okeson","year":"2008","unstructured":"Okeson JP (2008) The classification of orofacial pains. Oral Maxillofac Surg Clin North Am 20:133\u2013144","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"8_CR119","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4196\/kjpp.2009.13.6.425","volume":"13","author":"YB Kwon","year":"2009","unstructured":"Kwon YB, Jeong YC, Kwon JK, Son JS, Kim KW (2009) The antinociceptive effect of sigma-1 receptor antagonist, BD1047, in a capsaicin induced headache model in rats. Korean J Physiol Pharmacol 13:425\u2013429","journal-title":"Korean J Physiol Pharmacol"},{"key":"8_CR120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.pbb.2014.06.023","volume":"124","author":"K Pyun","year":"2014","unstructured":"Pyun K, Son JS, Kwon YB (2014) Chronic activation of sigma-1 receptor evokes nociceptive activation of trigeminal nucleus caudalis in rats. Pharmacol Biochem Behav 124:278\u2013283","journal-title":"Pharmacol Biochem Behav"},{"key":"8_CR121","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cden.2013.04.005","volume":"57","author":"R Benoliel","year":"2013","unstructured":"Benoliel R, Eliav E (2013) Primary headache disorders. Dent Clin N Am 57:513\u2013539","journal-title":"Dent Clin N Am"},{"key":"8_CR122","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1476-5381.1996.tb15160.x","volume":"117","author":"V Limmroth","year":"1996","unstructured":"Limmroth V, Lee WS, Moskowitz MA (1996) GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges. Br J Pharmacol 117:99\u2013104","journal-title":"Br J Pharmacol"},{"issue":"Suppl 2","key":"8_CR123","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1111\/j.1526-4610.2007.00817.x","volume":"47","author":"AG Herzog","year":"2007","unstructured":"Herzog AG (2007) Neuroactive properties of reproductive steroids. Headache 47(Suppl 2):S68\u2013S78","journal-title":"Headache"},{"key":"8_CR124","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainresbull.2016.02.012","volume":"121","author":"SG Kwon","year":"2016","unstructured":"Kwon SG, Yoon SY, Roh DH, Choi SR, Choi HS et al (2016) Peripheral neurosteroids enhance P2X receptor-induced mechanical allodynia via a sigma-1 receptor-mediated mechanism. Brain Res Bull 121:227\u2013232","journal-title":"Brain Res Bull"},{"key":"8_CR125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1248\/bpb.b13-00690","volume":"37","author":"DH Roh","year":"2014","unstructured":"Roh DH, Yoon SY (2014) Sigma-1 receptor antagonist, BD1047 reduces nociceptive responses and phosphorylation of p38 MAPK in mice orofacial formalin model. Biol Pharm Bull 37:145\u2013151","journal-title":"Biol Pharm Bull"},{"key":"8_CR126","unstructured":"Gris G, Portillo-Salido E, Vela JM, Zamanillo D, Merlos M (2014) Role of the sigma-1 receptor in post-operative pain in mice. 15th World Congress on Pain. Buenos Aires"}],"container-title":["Advances in Experimental Medicine and Biology","Sigma Receptors: Their Role in Disease and as Therapeutic Targets"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-50174-1_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T01:07:32Z","timestamp":1750122452000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-50174-1_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319501727","9783319501741"],"references-count":126,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-50174-1_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}